PIERIS PHARMACEUTICALS, INC. Quarterly Depreciation in USD from Q1 2014 to Q1 2020

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Depreciation history and growth rate from Q1 2014 to Q1 2020.
  • Pieris Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2020 was $339K, a 104% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2023 was $1.8M, a 21.7% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2022 was $2.3M, a 4.17% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Depreciation for 2021 was $2.4M, a 14.3% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2020 $339K +$173K +104% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q1 2019 $166K +$32K +23.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $134K +$34K +34% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $100K +$5.48K +5.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $94.5K +$16.4K +21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $78.1K -$17.4K -18.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q1 2014 $95.5K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.